Atul Pande - 24 Jul 2026 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Reporting relationship: Director
Issuer ticker: IMVT
Reported as of: 24 Jul 2026
Net transaction value: -$59,700
SEC form: 4
Accepted by SEC: 24 Jul 2026, 17:59:12 UTC
Prior SEC filing: 26 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Tiago Girao, attorney-in-fact for Atul Pande

Key filing fact

Atul Pande filed Form 4 for Immunovant, Inc. (IMVT) on 24 Jul 2026.

Key facts

This page summarizes Atul Pande's Form 4 filing for Immunovant, Inc. (IMVT).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Jul 2026, 17:59.

Change

Previous filing in this sequence was filed on 26 Jun 2026.
Current net transaction value: -$59,700.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001643071 Primary reporting owner

Pande Atul

Relationship: Director
Address: C/O IMMUNOVANT, INC., 1000 PARK FORTY PLAZA, SUITE 210, DURHAM
Signature: /s/ Tiago Girao, attorney-in-fact for Atul Pande
Signature date: 24 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMVT transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,500
Change %: +1.3%
Price: $8.43^*
Shares after: 118,231
Date: 24 Jul 2026
Ownership: Direct
Footnotes: F1

IMVT transaction

Common Stock

Sale

Transaction value: $59,700
Shares: -1,500
Change %: -1.3%
Price: $39.80
Shares after: 116,731
Date: 24 Jul 2026
Ownership: Direct
Footnotes: F1

IMVT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 20,000
Date: 24 Jul 2026
Ownership: By Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMVT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -1,500
Change %: -2.2%
Price: $0.000000^*
Shares after: 66,681
Date: 24 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,500
Exercise price: $8.43
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025.

Footnote F2

Reflects an award of stock options to purchase Common Shares that is fully vested.